FMP
Eli Lilly and Company
LLY
NYSE
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
734.57 USD
-16.88 (-2.3%)
Earnings
Dividends
We are unable to load the chart at this time.
Splits
We are unable to load the chart at this time.
From:
To:
Date
Revenue
Earnings
Estimated Earnings
Surprise
2025-05-01
12.73B
3.34
3.26
2.45%
2025-02-06
0
5.32
5.03
5.77%
2024-10-30
11.44B
1.18
1.47
-19.73%
2024-08-08
11.3B
3.92
2.6
50.77%
2024-04-30
8.77B
2.58
2.46
4.88%
2024-02-06
9.35B
2.49
2.22
12.16%
2023-11-02
9.5B
0.1
-0.08
-225.00%
2023-08-08
8.31B
2.11
1.98
6.57%
2023-04-27
6.96B
1.62
1.73
-6.36%
2023-02-02
7.3B
2.09
1.78
17.42%
2022-11-01
6.94B
1.98
1.92
3.13%
2022-08-04
6.49B
1.25
1.69
-26.04%
2022-04-28
7.81B
2.62
2.32
12.93%
2022-02-03
8B
2.49
2.51
-0.80%
2021-10-26
6.77B
1.94
1.98
-2.02%
2021-08-03
6.74B
1.87
1.89
-1.06%
2021-04-27
6.81B
1.87
2.13
-12.21%
2021-01-29
7.44B
2.75
2.35
17.02%
2020-10-27
5.74B
1.54
1.71
-9.94%
2020-07-30
5.5B
1.89
1.56
21.15%
2020-04-23
5.86B
1.75
1.48
18.24%
2020-01-30
6.11B
1.73
1.52
13.82%
2019-10-23
5.48B
1.48
1.41
4.96%
2019-07-30
5.64B
1.5
1.45
3.45%
2019-04-30
5.09B
1.33
1.32
0.76%
2019-02-06
6.44B
1.33
1.34
-0.75%
2018-11-06
6.06B
1.39
1.35
2.96%
2018-07-24
6.36B
1.5
1.31
14.50%
2018-04-24
5.7B
1.34
1.13
18.58%
2018-01-31
6.16B
1.14
1.08
5.56%
2017-10-24
5.66B
1.05
1.03
1.94%
2017-07-25
5.82B
1.11
1.05
5.71%
2017-04-25
5.23B
0.98
0.96
2.08%
2017-01-31
5.76B
0.95
0.99
-4.04%
2016-10-25
5.19B
0.88
0.96
-8.33%
2016-07-26
5.4B
0.86
0.86
0.00%
2016-04-26
4.87B
0.83
0.85
-2.35%
2016-01-28
5.38B
0.78
0.77
1.30%
2015-10-22
4.96B
0.89
0.76
17.11%
2015-07-23
4.98B
0.9
0.74
21.62%
2015-04-23
4.64B
0.87
0.76
14.47%
2015-01-30
5.12B
0.75
0.74
1.35%
2014-10-23
4.88B
0.66
0.66
0.00%
2014-07-24
4.94B
0.68
0.65
4.62%
2014-04-24
4.68B
0.7
0.7
0.00%
2014-01-30
5.81B
0.74
0.74
0.00%
2013-10-23
5.77B
1.11
1.04
6.73%
2013-07-24
5.93B
1.16
1
16.00%
2013-04-24
5.6B
1.14
1.05
8.57%
2013-01-29
5.96B
0.85
0.78
8.97%
2012-10-24
5.44B
0.79
0.83
-4.82%
2012-07-25
5.6B
0.83
0.77
7.79%
2012-04-25
5.6B
0.92
0.78
17.95%
2012-01-31
6.05B
0.87
0.81
7.41%
2011-10-20
6.15B
1.13
1.13
0.00%
2011-07-21
6.25B
1.18
1.18
0.00%
2011-04-18
5.84B
1.24
1.17
5.98%
2011-01-27
6.19B
1.11
1.1
0.91%
2010-10-21
5.65B
1.21
1.15
5.22%
2010-07-22
5.75B
1.24
1.1
12.73%
